Table 6.
Gene Symbol | Probe Identifier | Clinical Cohort | P-value | Level of Clinical Cohort | Hazard Ratio1 | Relevant literature references |
---|---|---|---|---|---|---|
Polr2d | 214144_at | Therapy | 0.0044 | Other | 0.35 (0.18-0.70) | [117]O |
R | 0.50 (0.31-0.81) | |||||
CRT | 0.68 (0.38-1.21) | |||||
None | 0.77 (0.43-1.39) | |||||
CRnoT | 0.93 (0.58-1.5) | |||||
Igf2bp3 | 203820_s_at | Gender | 0.0146 | Female | 1.02 (0.84-1.24) | [118]O |
Male | 1.29 (1.12-1.49) |
n/a, No association with any type of cancer found in literature;
1 Hazard ratio estimate (95% confidence interval);
G Gene confirmed in an independent glioblastoma multiforme study; the number between square brackets denotes the corresponding literature reference;
O Gene confirmed in an independent study on any other type of cancer; the number between square brackets denotes the corresponding literature reference.